Studies

Ongoing Studies

• Alzheimer’s Plasma Extension (APEX)
• A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer’s Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer’s Disease and Intermediate Amyloid (AHEAD 3-45 Study)

• A Study to Confirm Safety and Efficacy of BAN2401 in Participants With Early Alzheimer’s Disease (Clarity AD)
• A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer’s Disease (START STUDY)
• Alzheimer’s Disease Neuroimaging Initiative 4 (ADNI4)

Upcoming Studies

• Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer’s Disease (TARBELA-AD)
• Alzheimer’s Tau Platform: Master Protocol (ATP)
• Alzheimer’s National Registry for Treatment and Diagnostics(ALZ–NET)